Universitätsklinikum Hamburg-Eppendorf (UKE)

Hospital


Location: Hamburg, Germany (DE) DE

ISNI: 0000000121803484

ROR: https://ror.org/01zgy1s35

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Serum neurofilaments for motoneuron and dementia diseases: a German multicenter cohort study (2026) Barba L, Steinacker P, Halbgebauer S, Oeckl P, Landwehrmeyer B, Weishaupt J, Verde F, et al. Journal article Gender disparities in historical context, workforce structure, and decision-making (2026) Weissmann L, Hintelmann K, Corradini S Journal article Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 30 (2026) Barthel H, Brendel M, Albert N, Boecker H, Bouter C, Brumberg J, Buchert R, et al. Journal article Interception of molecular relapse in breast cancer: The SURVIVE HERoes study (NCT06643585). (2026) Janni W, Friedl TW, Huesmann ST, Rack B, Heublein S, Schäffler H, Mehmeti F, et al. Journal article Translating ctDNA into cutaneous melanoma care: An international expert survey (2026) Geidel G, Fekade N, Raabe K, Smit DJ, Adam L, Heidrich I, Rünger A, et al. Journal article Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland-part I-systematic literature review and existing evidence (2026) Weiß C, Vill K, Baumann M, Bernert G, Blaschek A, Eisenkölbl A, Flotats-Bastardas M, et al. Journal article Diagnostic performance of β-(1→3)-D-glucan, two Candida antigen, and five anti-Candida antibody assays in ICU patients with sepsis and high risk for invasive candidiasis: a secondary endpoint of the CandiSep randomized clinical trial (2026) Standl L, Huber T, Bloos F, Thomas-Rüddel D, Träger J, Kluge S, Fichtner F, et al. Journal article Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial (2026) Hörner M, Tretschock LM, John N, Ziegler P, Häberle L, Uhrig S, Goossens C, et al. Journal article Radiotherapy in patients with NSCLC developing progressive disease during immune checkpoint inhibition: Abscopal responses and survival (2026) Kaufmann J, Trommer M, Rühle A, Lamrani A, Frei C, Mäurer M, Wurschi G, et al. Journal article Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis (2026) Wurschi GW, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, Diefenhardt M, et al. Journal article